Tab 1: Survivin for breast cancer diagnosis and detection.
Year/first author/reference | Alone or combined | Assay | Collection | Conclusions |
2002/Nasu S (63) | alone | RT-PCR 37/41 (90.2%) | specimen | a useful diagnostic marker for breast cancer. |
2002/Izawa A (64) | with c-erbB2 and PLU-1 | RT-PCR27/39 (69.2%) | specimen | useful as a marker for diagnosis |
2006/Yie SM (60) | alone | RT-PCR ELISA | PB | PPV in vessel infiltration, histological grade, tumor size, nodal status, ER/PgR status, Her-2 status and clinical stages |
2006/Chen CC (61) | with PTTG1, UbcH10 and TK1 | membrane array technique | PB | PPV in tumor size, histologic grade, lymph node metastasis and TNM stage |
2006/Guney N (62) | alone | EIA and ELISA | Serum and urine | serum survivin level could be a sensitive marker for detecting metastases in lymph nodes |
2009/Shen C (65) | with hTERT and hMAM | real-time q PCR | PB | PPV in TNM stage, and lymph node metastasis |
PPV: positive predictive value, NPV: negative predictive value, (q) RT-PCR, (quantitative) reverse transcriptase polymerase chain reaction, ELISA, enzyme linked immunosorbent assay, PB, peripheral blood.